Has Jesse Herrman received payments from drug or device companies?

Yes. Drug and device makers reported $2,996 in general payments to Jesse Herrman across 144 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jesse Herrman did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jesse Herrman come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jesse Herrman

Psychiatric/Mental Health · Columbus, INNPI 1154198562

Payments from drug & device makers

$2,996in general payments, 2019–2025

Across 144 payments — averaging $20.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$771
Vanda Pharmaceuticals Inc.$533
Johnson & Johnson$199
Alkermes, Inc.$198
AbbVie$191
E.r. Squibb & Sons, L.L.C.$190
plus $914 from 12 others

What the payments were for

Food & beverage$2,988100%
Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	36	$771
Vanda Pharmaceuticals Inc.	14	$533
Johnson & Johnson	10	$199
Alkermes, Inc.	15	$198
AbbVie	15	$191
E.r. Squibb & Sons, L.L.C.	6	$190
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	9	$158
Neurocrine Biosciences, Inc.	7	$141
Indivior Inc.	8	$127
Axsome Therapeutics, Inc.	2	$114
Lundbeck LLC	3	$73
Teva Pharmaceuticals USA, Inc.	4	$72
Takeda Pharmaceuticals U.S.A., Inc.	3	$61
Corium, LLC	6	$48
Collegium Pharmaceutical, Inc.	2	$42
Luye Pharma (USA) Ltd.	1	$34
Supernus Pharmaceuticals, Inc.	2	$31
Vertical Pharmaceuticals, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,996 in reported general payments places this provider in the 80th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	16	$54,793
CaplytaLumateperone Tosylate	29	$50,842
VraylarCariprazine Hcl	27	$37,361
RexultiBrexpiprazole	11	$16,169
AuvelityDextromethorphan Hbr/Bupropion	12	$6,916
Aripiprazole	34	$5,109
Paliperidone ErPaliperidone	14	$3,308
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	20	$2,851
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	16	$2,102
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	12	$2,088
Lurasidone Hcl	13	$2,084
Prazosin Hcl	42	$1,064
Buspirone Hcl	68	$991
Hydroxyzine Hcl	29	$816
Divalproex Sodium ErDivalproex Sodium	11	$671

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna	$199	$54,79316 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$158	$50,84229 claims
AbbVieVraylar	$191	$37,36127 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$771	$16,16911 claims
Axsome Therapeutics, Inc.Auvelity	$114	$6,91612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Columbus

Lauren LutzColumbus$320K
Ruth BaileyColumbus$6K
Brooke KempfTerre Haute$1.1M
Gerald LewisMerrillville$336K
Sonya RuedlingerIndianapolis$134K
Trina GreenwaldMarion$107K
Paul DuncanJeffersonville$46K
Morgan StamperConnersville$42K
Jennifer JimenezUnion Mills$37K
Savannah MullinsClarksville$31K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →